Continuous Ingestion of a Standardized Extract of Cultured Lentinula edodes Mycelia Suppresses Spontaneous Carcinogenesis in a Murine Model
Biological and Pharmaceutical Bulletin · 2025
DOI: 10.1248/bpb.b24-00641 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biological and Pharmaceutical Bulletin, 2025. Verfasst von Shigeki Adachi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cellular Immunology, RIMD, Osaka University, 3-1 Yamadaoka, Suita, Osaka 565-0871, Japan. Hauptthemen laut MEDLINE: Shiitake Mushrooms, Carcinogenesis, Breast Neoplasms, Liver Neoplasms. Die Arbeit nennt 26 Literaturangaben.
Abstract (Originalsprache)
AHCC®, a standardized extract of cultured Lentinula edodes mycelia, suppresses the proliferation of both cancer cell line-derived and patient-derived xenografts transplanted into mice. However, the mechanism of action underlying the suppressive effect of AHCC on spontaneous carcinogenesis remains unclear. This study investigated the effects of long-term AHCC ingestion on spontaneous carcinogenesis and the health of C3H/HeJ mice. The mice were divided into three groups: A (2% AHCC ingestion continuously 2 d a week), B (2% AHCC ingestion daily), and C (water ingestion). The ingestion of AHCC or water was started when mice were 5 weeks old and were observed until 24 months of age. The occurrence of the first death was delayed in the AHCC-ingestion groups, and the survival rates were significantly higher in the AHCC-ingestion groups than in the control group. The proportion of "healthy mice" with no morphological abnormalities in their organs was also significantly higher in the AHCC-ingestion groups than in the control group. Furthermore, the incidence of cancer-bearing mice, particularly breast cancer and liver cancer, was significantly reduced in the AHCC-ingestion groups. The reduced rates of breast cancer were particularly higher among females of the AHCC-ingestion groups, whereas the reduced rates of liver cancer were higher among males of the AHCC-ingestion groups. These results suggest that continuous AHCC ingestion maintains health and prevents spontaneous carcinogenesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cellular Immunology, RIMD, Osaka University, 3-1 Yamadaoka, Suita, Osaka 565-0871, Japan.
- Amino Up Co., Ltd., 363-32 Shin-ei, Kiyota-ku, Sapporo 004-0839, Japan.
- Faculty of Pharmaceutical Sciences, Department of Pharmacy, Hokkaido University of Science, 15-4-1 Maeda 7, Teine-ku, Sapporo 006-8585, Japan.
- Department of Immunology, Graduate School of Biomedical Sciences, Nagasaki University, 1-12-4 Sakamoto, Nagasaki 852-8523, Japan.
- Graduate School of Medicine, Faculty of Medicine, Osaka University, 2-2 Yamadaoka, Suita Osaka 565-0871, Japan.
Zitieren
APA
Adachi, S., Tougan, T., Ryo, H., Takanari, J., Wakame, K., Aoshi, T., & Nomura, T. (2025). Continuous Ingestion of a Standardized Extract of Cultured Lentinula edodes Mycelia Suppresses Spontaneous Carcinogenesis in a Murine Model. Biological and Pharmaceutical Bulletin. https://doi.org/10.1248/bpb.b24-00641
Vancouver
Adachi S, Tougan T, Ryo H, Takanari J, Wakame K, Aoshi T, et al. Continuous Ingestion of a Standardized Extract of Cultured Lentinula edodes Mycelia Suppresses Spontaneous Carcinogenesis in a Murine Model. Biological and Pharmaceutical Bulletin. 2025. doi:10.1248/bpb.b24-00641
BibTeX
@article{Adachi2025,
author = {Adachi, Shigeki and Tougan, Takahiro and Ryo, Haruko and Takanari, Jun and Wakame, Koji and Aoshi, Taiki and Nomura, Taisei},
title = {Continuous Ingestion of a Standardized Extract of Cultured Lentinula edodes Mycelia Suppresses Spontaneous Carcinogenesis in a Murine Model},
journal = {Biological and Pharmaceutical Bulletin},
year = {2025},
doi = {10.1248/bpb.b24-00641}
}
EUVIMED